SANTA CLARA, Calif. -- Crown Bioscience, a
wholly-owned subsidiary of Crown Bioscience International (TWSE: ticker 6554)
and a global drug discovery and development services company providing
translational platforms to advance oncology and metabolic disease research,
has launched an e-commerce platform to support the commercialization of its
Life Science products.
The launch follows the recent expansion of CrownBio's Life Science division
and answers the need to accommodate an increasing demand for the Company's
products.
CrownBio's clients will now be able to purchase hundreds of products online
across a portfolio consisting of: antibodies for in vivo and in vitro studies,
recombinant proteins and cell lines, immune checkpoint antibodies, and tumor
tissue microarrays.
This digital tool facilitates and accelerates clients' ordering, enabling them
to create online accounts to track the history of their previous orders, save
and share quotations for pending approval, and conveniently process
transactions.
"We have created a digital user-friendly experience. Our platform has been
updated to meet client expectations and provide an improved opportunity to
purchase and deliver products online at CrownBio," commented Debby Saunders,
Executive Director of Life Science Development at CrownBio.
"We remain impressed by the incredible growth and development of every
division at CrownBio," stated Laurie Heilmann, SVP of Global Strategy,
Marketing and Business Development. "In the Life Science sector, I am pleased
we could successfully pivot CrownBio digital engagement efforts with the
development of the e-commerce platform, which will ensure a client friendly,
efficient experience to purchasing our products."
CrownBio's online shop can be accessed from the company website at this
link https://instrumentbusinessoutlook.com/wp-content/uploads/sites/2/dlm_uploads/2016/05/235-prod_mgr_workshop.pdf
For more information on CrownBio's commitment to furthering the field of
oncology and metabolic disease drug discovery, visit https://www.crownbio.com.
About Crown Bioscience Inc.
Crown Bioscience is a global drug discovery and development solutions company
providing translational platforms to advance oncology and metabolic disease
research. With an extensive portfolio of relevant models and predictive tools,
Crown Bioscience enables clients to deliver superior clinical candidates.
